The Enterprise Value as of December 2025 (TTM) for Hansa Biopharma AB (publ) (HNSBF) is 3.51B

According to Hansa Biopharma AB (publ)’s latest financial reports and current stock price. The company's current Enterprise Value is 3.51B. This represents a change of 16.81% compared to the average of 3.00B of the last 4 quarters.

Hansa Biopharma AB (publ) (HNSBF) Historical Enterprise Value (quarterly & annually)

How has HNSBF Enterprise Value performed in the past?

The mean historical Enterprise Value of Hansa Biopharma AB (publ) over the last ten years is 4.49B. The current 3.51B Enterprise Value has changed 7.72% with respect to the historical average. Over the past ten years (40 quarters), HNSBF's Enterprise Value was at its highest in in the September 2018 quarter at 12.40B. The Enterprise Value was at its lowest in in the December 2015 quarter at 644.43M.

Hansa Biopharma AB (publ) (HNSBF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Hansa Biopharma AB (publ) Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Hansa Biopharma AB (publ) (HNSBF) Average Enterprise Value

How has HNSBF Enterprise Value performed in the past?

The current Enterprise Value of Hansa Biopharma AB (publ) (HNSBF) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Hansa Biopharma AB (publ) (HNSBF) Enterprise Value vs. Peers

How is HNSBF’s Enterprise Value compared to its peers?

Hansa Biopharma AB (publ)’s Enterprise Value is greater than Silence Therapeutics plc (246.06M), greater than Transgene S.A. (135.53M), less than Probi AB (publ) (3.70B), greater than Cellectis S.A. (379.59M), greater than Santhera Pharmaceuticals Holding AG (217.29M), greater than Immutep Limited (316.92M), greater than Genfit S.A. (258.87M), greater than Frontage Holdings Corporation (372.31M), greater than hVIVO plc (2.81M), greater than Mayne Pharma Group Limited (242.23M),

Build a custom stock screener for Hansa Biopharma AB (publ) (HNSBF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hansa Biopharma AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Hansa Biopharma AB (publ) (HNSBF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Hansa Biopharma AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.